Published in Am J Pharm Educ on December 17, 2009
Pharmacy residencies and dual degrees as complementary or competitive advanced training opportunities. Am J Pharm Educ (2012) 1.87
An elective course in leader development. Am J Pharm Educ (2013) 1.10
Integration of physical assessment within a pathophysiology course for pharmacy. Am J Pharm Educ (2012) 1.07
Development and assessment of social and emotional competence through simulated patient consultations. Am J Pharm Educ (2012) 0.84
Where are the postgraduate programs for tomorrow's education administrative leaders? Am J Pharm Educ (2011) 0.80
Factors influencing pharmacy students' attitudes towards pharmacy practice research and strategies for promoting research interest in pharmacy practice. Pharm Pract (Granada) (2015) 0.78
Pamphlet as a tool for continuing medical education: performance assessment in a randomized controlled interventional study. Med J Islam Repub Iran (2015) 0.78
Variety and quantity of professional electives. Am J Pharm Educ (2012) 0.78
Pharmacy education in Saudi Arabia: A vision of the future. Saudi Pharm J (2016) 0.75
First-Year Pharmacy Students' Views on Their Chosen Professional Career. Am J Pharm Educ (2016) 0.75
Using Social Cognitive Theory to Explain the Intention of Final-year Pharmacy Students to Undertake a Higher Degree in Pharmacy Practice Research. Am J Pharm Educ (2016) 0.75
A career exploration assignment for first-year pharmacy students. Am J Pharm Educ (2013) 0.75
Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev (1977) 59.24
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis (2006) 14.63
American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy (2006) 9.72
A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med (2009) 9.45
Factors influencing the pharmacy faculty workforce. Am J Pharm Educ (2008) 5.77
Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy (2007) 4.60
Self-assessment in the health professions: a reformulation and research agenda. Acad Med (2005) 4.21
Pharmacy student response to patient-simulation mannequins to teach performance-based pharmacotherapeutics. Am J Pharm Educ (2006) 3.72
Simulation-based learning to teach blood pressure assessment to doctor of pharmacy students. Am J Pharm Educ (2007) 3.41
Human patient simulation in a pharmacotherapy course. Am J Pharm Educ (2008) 3.23
Using a human patient simulation mannequin to teach interdisciplinary team skills to pharmacy students. Am J Pharm Educ (2007) 2.86
An interprofessional activity using standardized patients. Am J Pharm Educ (2006) 2.47
Academic pharmacy administrators' perceptions of core requirements for entry into professional pharmacy programs. Am J Pharm Educ (2008) 2.19
Simulated patients vs. standardized patients in objective structured clinical examinations. Am J Pharm Educ (2006) 2.05
Research skills training for the doctor of pharmacy in U.S. schools of pharmacy: a descriptive study. Int J Pharm Pract (2009) 1.87
Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists. Pharmacotherapy (2004) 1.71
Integrating virtual patients into a self-care course. Am J Pharm Educ (2007) 1.70
The Pharm.D. investigator in clinical pharmacology: supply and demand. Clin Pharmacol Ther (2008) 1.67
The design and evaluation of a simulated-patient teaching programme to develop the consultation skills of undergraduate pharmacy students. Pharm World Sci (2001) 1.62
The research agenda of the American College of Clinical Pharmacy. Pharmacotherapy (2007) 1.61
Pharmacy students' preferences for various types of simulated patients. Am J Pharm Educ (2008) 1.58
An evidence-based model of effective self-assessment for directing professional learning. J Dent Educ (2005) 1.57
Report of the ASHP Task Force on Pharmacy's Changing Demographics. Am J Health Syst Pharm (2007) 1.45
Utilization of the Center for the Advancement of Pharmaceutical Education Educational outcomes, revised version 2004: report of the 2005 American College of Clinical Pharmacy Educational Affairs Committee. Am J Pharm Educ (2006) 1.08
Computer-based patient simulations: hospital pharmacists' performance and opinions. Am J Hosp Pharm (1992) 1.05
The Iowa Continuity of Care study: Background and methods. Am J Health Syst Pharm (2008) 0.96
The Pharm.D. investigator in clinical pharmacology: supply and demand. Clin Pharmacol Ther (2008) 0.88
Instructing pharmacy students with interactive clinical cases. Am J Health Syst Pharm (2008) 0.82
Clinical prevention and population health: curriculum framework for health professions. Am J Prev Med (2004) 3.76
An automated competency-based student performance assessment program for advanced pharmacy practice experiential programs. Am J Pharm Educ (2007) 2.68
A pharmacy course on leadership and leading change. Am J Pharm Educ (2009) 1.84
Educating students for practice: educational outcomes and community experience. Am J Pharm Educ (2006) 1.82
Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate. Clin Cancer Res (2008) 1.82
An environmental scan on the status of critical thinking and problem solving skills in colleges/schools of pharmacy: report of the 2009-2010 academic affairs standing committee. Am J Pharm Educ (2010) 1.80
Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia. Leuk Lymphoma (2012) 1.57
An elective course in adult acute care medicine using a hybrid delivery system. Am J Pharm Educ (2008) 1.55
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia. Oncologist (2013) 1.52
Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies. Proc Natl Acad Sci U S A (2010) 1.49
Student leadership retreat focusing on a commitment to excellence. Am J Pharm Educ (2009) 1.45
U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma. Clin Cancer Res (2012) 1.41
Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc (2003) (2007) 1.37
Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi. Antimicrob Agents Chemother (2005) 1.35
U.S. Food and Drug Administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosis. Clin Cancer Res (2012) 1.31
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma. Clin Cancer Res (2013) 1.27
A Web-based interprofessional diabetes education course. Am J Pharm Educ (2007) 1.26
Instruction for student pharmacists on leading change. Am J Pharm Educ (2009) 1.23
Increased nociceptive response in mice lacking the adenosine A1 receptor. Pain (2005) 1.16
Three-dimensional clavicular motion during arm elevation: reliability and descriptive data. J Orthop Sports Phys Ther (2004) 1.05
Refinement of strengths instruction in a pharmacy curriculum over eight years. Am J Pharm Educ (2011) 1.05
Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice. Biopharm Drug Dispos (2012) 1.04
A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma. Br J Haematol (2012) 1.02
Syncope and head CT scans in the emergency department. Emerg Radiol (2005) 1.01
Ixabepilone in combination with capecitabine and as monotherapy for treatment of advanced breast cancer refractory to previous chemotherapies. Clin Cancer Res (2008) 1.00
Report of the AACP task force on patient-centered medical homes and accountable care organizations. Am J Pharm Educ (2013) 0.98
The roles of healthcare professionals in implementing clinical prevention and population health. Am J Prev Med (2011) 0.96
Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paper. Bioanalysis (2013) 0.96
An advanced pharmacy practice experience in inpatient medication education. Am J Pharm Educ (2009) 0.94
Investigating student pharmacist perceptions of professional engagement using a modified Delphi process. Am J Pharm Educ (2012) 0.94
Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary. Clin Cancer Res (2010) 0.93
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events. Br J Haematol (2014) 0.93
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor. Cancer Chemother Pharmacol (2015) 0.90
Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study. BMC Clin Pharmacol (2008) 0.89
AACP Council of Deans report, July 2013. Am J Pharm Educ (2013) 0.89
Tobacco sales in pharmacies: a survey of attitudes, knowledge and beliefs of pharmacists employed in student experiential and other worksites in Western New York. BMC Res Notes (2012) 0.88
Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis. Dement Geriatr Cogn Disord (2004) 0.88
Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors. Invest New Drugs (2013) 0.87
A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone). J Clin Pharmacol (2007) 0.85
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer. Ann Pharmacother (2012) 0.85
Transcranial Doppler: an introduction for primary care physicians. J Am Board Fam Med (2007) 0.85
Using the Clinical Prevention and Population Health Curriculum Framework to encourage curricular change. Am J Prev Med (2011) 0.84
Management of age-related osteoporosis and prevention of associated fractures. Ther Clin Risk Manag (2006) 0.83
Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction. MAbs (2014) 0.83
The imperative for interprofessional education. Am J Pharm Educ (2009) 0.82
The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases. Cancer Biother Radiopharm (2005) 0.82
Transcranial Doppler measurements in migraine and nitroglycerin headache. J Headache Pain (2007) 0.78
Inhaled aztreonam lysine: an evidence-based review. Expert Opin Pharmacother (2013) 0.78
Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks. Antimicrob Agents Chemother (2007) 0.78
Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis. P T (2011) 0.78
Pharmacotherapy of fibromyalgia. Am J Health Syst Pharm (2011) 0.77
Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression? J Pediatr Pharmacol Ther (2011) 0.76
Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography. Ann Pharmacother (2002) 0.75
Instructor satisfaction with a technology-based resource for diabetes education. Am J Pharm Educ (2009) 0.75
"Community of learning" in experiential education. Am J Pharm Educ (2007) 0.75
Treatment of headache in the elderly. Curr Treat Options Neurol (2013) 0.75
Compounded versus proprietary sincalide for evaluation of gallbladder ejection fraction. Ann Pharmacother (2004) 0.75
Conference report: hot topics in antibody-drug conjugate development. Bioanalysis (2013) 0.75
Discovery of the hemifumarate and (alpha-L-alanyloxy)methyl ether as prodrugs of an antirheumatic oxindole: prodrugs for the enolic OH group. J Med Chem (1996) 0.75